FDA approves Merck's Emend injection for nausea

01/30/2008 | CNNMoney

Merck & Co. on Tuesday announced that the FDA has approved its Emend injection for the prevention of chemotherapy-induced nausea. The approval covers the drug's 115-mg dosage for use in combination with other treatments for acute and delayed nausea and vomiting due to cancer chemotherapy. The company also said that the injection can replace the 125-mg oral capsule version of Emend.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ